Analysis of Serum Exosomes in Patients with Colorectal and Breast Cancer

$57,816U54FY2013CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications & trials

Paper 39711546 Paper 39254315 Paper 39133759 Paper 39087753 Paper 38900224 Paper 38886716 Paper 38732686 Paper 38491559 Paper 38237908 Paper 37782499 Paper 37765691 Paper 37721666 Paper 37603225 Paper 37594293 Paper 37298325 Paper 37014680 Paper 36922114 Paper 36922108 Paper 36922105 Paper 36823545 Paper 36550466 Paper 36071314 Paper 36049656 Paper 35759626 Paper 35703177 Paper 35416993 Paper 35153231 Paper 35088206 Paper 34774792 Paper 34756753 Paper 34741221 Paper 34438316 Paper 34432217 Paper 34046808 Paper 33947654 Paper 32493245 Paper 31967672 Paper 31563898 Paper 31160346 Paper 30642558 Paper 30365870 Paper 29609838 Paper 29435066 Paper 29317652 Paper 28840823 Paper 28469253 Paper 28351997 Paper 28304339 Paper 28153042 Paper 28018190 Paper 27980415 Paper 27902559 Paper 27884047 Paper 27882696 Paper 27826542 Paper 27822710 Paper 27773529 Paper 27709126 Paper 27607467 Paper 27602597 Paper 27356744 Paper 27185338 Paper 27128983 Paper 27128153 Paper 25927530 Paper 25734985 Paper 25664328 Paper 25596733 Paper 25524808 Paper 25469981 Paper 25450700 Paper 25421380 Paper 25382723 Paper 25381262 Paper 25341744 Paper 25321409 Paper 25258648 Paper 25250685 Paper 25212505 Paper 25194507 Paper 25152898 Paper 25147619 Paper 25144771 Paper 25107658 Paper 25099011 Paper 25078150 Paper 25052906 Paper 25010677 Paper 24910389 Paper 24874702 Paper 24830293 Paper 24567661 Paper 24562910 Paper 24554393 Paper 24491412 Paper 24469401 Paper 24452759 Paper 24423614 Paper 24332981 Paper 24173214

Abstract

A major strength of this proposal is the blending of the complementary expertise of the two labs in breast and colorectal cancer with a shared interest in exosomes, enabling the formation of a true partnership to establish a clinically applicable method to measure selected proteins in exosomes from the serum of cancer patients. We anticipate that the reliable detection and precise quantification of selected proteins in serum exosomes may enable the eariier diagnosis of patients with breast and colorectal cancer. However, the pilot project will establish normal standards for serum exosomes in normal individuals, and then, initially, compare these results to patients with early and advanced colorectal cancer and advanced breast cancer. As the work progresses, analysis of serum exosomes may prove to have prognostic and predictive value in the management of patients with cancer [1].

View original record on NIH RePORTER →